Head-to-head · Value Score
Trimi Health vs Synergy Rx
Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Synergy Rx a 69. Here's who gives you the honest lower price — and where each one bites back.
Trimi Health
#3 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameSynergy Rx
#41 · Grade C · Watch List
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
Trimi Health takes it on Value Score, 89 to 69 — an est. $99/mo first month, with no teaser step-up baked in. Synergy Rx isn't out of it: Shoppers who want brand Wegovy, Ozempic or Mounjaro and will accept getting pricing by enquiry.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Trimi Health | Synergy Rx |
|---|---|---|
| Value Score | 89 (A) | 69 (C) |
| Est. first month | $99/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | From $199/mo |
| Tirzepatide | $125/mo | From $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Trimi Health
The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.
Why it's a deal
- Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
- Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
- Nationwide 50-state reach, so the low price isn't gated to a handful of states
The fine print
- Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
- Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
- Newer brand with a thin public track record
Synergy Rx
A brand-name lane and unlimited clinical contact, at prices you cannot see until you are inside.
Why it's a deal
- Prescribes FDA-approved brand Wegovy, Ozempic and Mounjaro when clinically appropriate
- Unlimited appointments, unlimited messaging and 24/7 access to a dedicated clinical team
- $100 welcome credit at checkout, and FSA/HSA eligible
The fine print
- Publishes no GLP-1 price anywhere on its own site
- At $349/mo tirzepatide sits roughly $100 above the compounded median we track
- Does not publish which states it serves, or any cancellation terms
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.